Late-breaking Abstracts are Welcome!
Deadline – August 1 

We are happy to announce that the Europe Biobank Week 2021 received a significant amount of abstracts already! And now we are welcoming late-breaking abstracts until the 1st of August.

Be sure to submit your abstract under one of the following topics and get a chance to become a speaker at #EBW21 as we select oral presentations for congress sessions from abstract submissions:

•Population-based cohorts – addressing global challenges for future generations
•Biobanking for our environment: plant biobanking, species preservation and crop opportunities
•Biobanking and Exposure Science
•Patient Engagement
•Regulatory Implications
•Biological Quality in Biobanking
•Pediatric Biobanking
•Novel IT solutions, effective data storage, processing and analysis
•Biobanking for our Environment: Animal Biobanking and Species Preservation
•Biobanking in Personalized Medicine
•Rare disease collections – The Treasures of the Biobanks
•Pitch your innovative ideas!
•Museum biobanking: old opportunities not lost

No further deadline extension is foreseen. Share your expertise now!
Submit your abstract before August 1st.

The Role of Biobanks and Human Biomonitoring
for Human Health – Its value for policy making and its future perspective in Europe
Don’t miss #EBW21 Keynote address 

Join us for the Keynote address of Dr. Marike Kolossa-Gehring
Head of Section Toxicology, Health related Environmental Monitoring, German Environment Agency

“The role of Biobanks and Human Biomonitoring for Human Health – Its value for policy”.

Session date & time:
Tuesday, 9 November
11:30 – 12:30 CET

Dr. Marike Kolossa-Gehring is biologist and toxicologist, Head of Section “Toxicology, Health related Environmental Monitoring” and coordinator of the European Joint Programme HBM4EU, a joint effort of 120 partners from 30 countries, the European Environment Agency and the European Commission. At UBA she is in charge of the German Federal Human Biomonitoring Program consisting of German Environmental Survey (GerES), the human samples of the German Environmental Specimen Bank (ESB), the Human Biomonitoring Commission, and the HBM cooperation between the German Chemical Industry Association (VCI) and the Federal Ministry for the Environment (BMU).

Dr. Marike Kolossa-Gehring was involved in developing assessment strategies/guidelines at national, EU and OECD level, vice-chair and chair of the OECD Endocrine Disruptor Testing and Assessment Task Force (2006 to 2010). She was Work Package Leader in the EU-HBM projects ESBIO, DEMOCOPHES/COPHES, Councillor of the International Society of Exposure Science (ISES) and is Advisory Board member of Fraunhofer IBMT.
At #EBW21, Dr. Marike Kolossa-Gehring will put the spotlight on the role of biobanks and human biomonitoring for human health and its value for policy.